[Arsenic trioxide in the treatment of advanced primary liver and gallbladder cancer].
To evaluate the effect and toxicity of arsenic trioxide (As2O3) in treating primary liver and gallbladder cancer. Twenty-nine advanced primary liver cancer and 4 gallbladder cancer patients were treated with As2O3 injection only, 15 mg i.v. qd for 14-21 days and was repeated after 2 weeks. The overall response rate was 15.2%, 13.8% in primary liver cancer (PR 4, NC 21 and PD 4). It was 25.0% in gallbladder cancer (CR 1, NC 2, PD 1). The major side reactions were mild bone marrow suppression and hepatic functional damage. As2O3 injection is effective in treating primary liver and gallbladder cancer with mild side reactions. It is worth studying in the future.